306 related articles for article (PubMed ID: 25088927)
1. Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes.
Chong CR; Chan WP; Nguyen TH; Liu S; Procter NE; Ngo DT; Sverdlov AL; Chirkov YY; Horowitz JD
Cardiovasc Drugs Ther; 2014 Aug; 28(4):347-60. PubMed ID: 25088927
[TBL] [Abstract][Full Text] [Related]
2. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.
Connelly KA; Advani A; Advani SL; Zhang Y; Kim YM; Shen V; Thai K; Kelly DJ; Gilbert RE
Acta Diabetol; 2014 Oct; 51(5):771-82. PubMed ID: 24925443
[TBL] [Abstract][Full Text] [Related]
3. The thioredoxin system as a therapeutic target in human health and disease.
Mahmood DF; Abderrazak A; El Hadri K; Simmet T; Rouis M
Antioxid Redox Signal; 2013 Oct; 19(11):1266-303. PubMed ID: 23244617
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer.
Li W; Wu Z; Ma Q; Liu J; Xu Q; Han L; Duan W; Lv Y; Wang F; Reindl KM; Wu E
Curr Cancer Drug Targets; 2014; 14(4):348-56. PubMed ID: 24720336
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor activation in a diabetic-like environment: potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways.
Zitman-Gal T; Golan E; Green J; Bernheim J; Benchetrit S
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):1-7. PubMed ID: 22531461
[TBL] [Abstract][Full Text] [Related]
6. trans-Resveratrol downregulates Txnip overexpression occurring during liver ischemia-reperfusion.
Nivet-Antoine V; Cottart CH; Lemaréchal H; Vamy M; Margaill I; Beaudeux JL; Bonnefont-Rousselot D; Borderie D
Biochimie; 2010 Dec; 92(12):1766-71. PubMed ID: 20709139
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid Upregulates Thioredoxin-interacting Protein in Cultured Neuronal Cells.
Bharti V; Tan H; Chow D; Wang Y; Nagakannan P; Eftekharpour E; Wang JF
Neuroscience; 2018 Aug; 384():375-383. PubMed ID: 29894818
[TBL] [Abstract][Full Text] [Related]
8. Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization.
Ogata FT; Batista WL; Sartori A; Gesteira TF; Masutani H; Arai RJ; Yodoi J; Stern A; Monteiro HP
PLoS One; 2013; 8(12):e84588. PubMed ID: 24376827
[TBL] [Abstract][Full Text] [Related]
9. [Thioredoxin-interacting protein: a new potential target for diabetes and related vascular complications therapy].
Wu P; Du GH
Yao Xue Xue Bao; 2015 Dec; 50(12):1559-64. PubMed ID: 27169277
[TBL] [Abstract][Full Text] [Related]
10. Rare sugar D-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells.
Yamada K; Noguchi C; Kamitori K; Dong Y; Hirata Y; Hossain MA; Tsukamoto I; Tokuda M; Yamaguchi F
Nutr Res; 2012 Feb; 32(2):116-23. PubMed ID: 22348460
[TBL] [Abstract][Full Text] [Related]
11. The thioredoxin antioxidant system.
Lu J; Holmgren A
Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
[TBL] [Abstract][Full Text] [Related]
12. Advances in the Functions of Thioredoxin System in Central Nervous System Diseases.
Jia J; Xu G; Zhu D; Liu H; Zeng X; Li L
Antioxid Redox Signal; 2023 Feb; 38(4-6):425-441. PubMed ID: 35761787
[No Abstract] [Full Text] [Related]
13. Thioredoxin Interacting Protein Inhibitors in Diabetes Mellitus: A Critical Review.
Kar A; Paramasivam B; Jayakumar D; Swaroop AK; Jubie S
Curr Drug Res Rev; 2023; 15(3):228-240. PubMed ID: 36786139
[TBL] [Abstract][Full Text] [Related]
14. Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.
Nasoohi S; Ismael S; Ishrat T
Mol Neurobiol; 2018 Oct; 55(10):7900-7920. PubMed ID: 29488135
[TBL] [Abstract][Full Text] [Related]
15. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells.
Yamawaki H; Pan S; Lee RT; Berk BC
J Clin Invest; 2005 Mar; 115(3):733-8. PubMed ID: 15696199
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.
Spindel ON; World C; Berk BC
Antioxid Redox Signal; 2012 Mar; 16(6):587-96. PubMed ID: 21929372
[TBL] [Abstract][Full Text] [Related]
17. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2.
Watanabe R; Nakamura H; Masutani H; Yodoi J
Pharmacol Ther; 2010 Sep; 127(3):261-70. PubMed ID: 20435060
[TBL] [Abstract][Full Text] [Related]
18. A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression.
Chai TF; Hong SY; He H; Zheng L; Hagen T; Luo Y; Yu FX
Cell Signal; 2012 Aug; 24(8):1700-5. PubMed ID: 22561086
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
Holmgren A; Lu J
Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
[TBL] [Abstract][Full Text] [Related]
20. The structural basis for the negative regulation of thioredoxin by thioredoxin-interacting protein.
Hwang J; Suh HW; Jeon YH; Hwang E; Nguyen LT; Yeom J; Lee SG; Lee C; Kim KJ; Kang BS; Jeong JO; Oh TK; Choi I; Lee JO; Kim MH
Nat Commun; 2014; 5():2958. PubMed ID: 24389582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
